THURSDAY, March 1 (HealthDay News) -- Two drugs that continuation the digestion-aiding actions of pancreatic enzymes be seized of been approved by the U.S. Food and drug Administration, the agency said Thursday in a recent accounts release.

Ultresa (pancrelipase) was approved during the term of adults and children with cystic fibrosis and other disorders that relate to food digestion because the pancreas does not bear enough enzymes, the FDA said.

The helper drug, Viokace (pancrelipase), is to have existence used in combination with a proton cross-question inhibiting medication to treat adults through pancreatitis -- a chronic inflammation of the pancreas. This unsalable article's safety and effectiveness have not been established in children, the agency said.

About 200,000 people in the United States gain "pancreatic insufficiency" disorders, according to the FDA. The two new medications are the 4th and 5th to exist approved for these conditions.

Both renovated drugs are produced by Aptalis Pharma US, based in Bridgewater, N.J.

More accusation

Medline Plus has more about pancreatic diseases.

@yahoonews without ceasing Twitter, become a fan on Facebook